IT201600072450A1 - Composizione farmaceutica a base di cellulasi per l’uso nel trattamento di malattie oculari. - Google Patents

Composizione farmaceutica a base di cellulasi per l’uso nel trattamento di malattie oculari.

Info

Publication number
IT201600072450A1
IT201600072450A1 IT102016000072450A IT201600072450A IT201600072450A1 IT 201600072450 A1 IT201600072450 A1 IT 201600072450A1 IT 102016000072450 A IT102016000072450 A IT 102016000072450A IT 201600072450 A IT201600072450 A IT 201600072450A IT 201600072450 A1 IT201600072450 A1 IT 201600072450A1
Authority
IT
Italy
Prior art keywords
cellulases
treatment
pharmaceutical composition
composition based
ocular diseases
Prior art date
Application number
IT102016000072450A
Other languages
English (en)
Inventor
Francesco Sabatino
Original Assignee
Francesco Sabatino
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Francesco Sabatino filed Critical Francesco Sabatino
Priority to IT102016000072450A priority Critical patent/IT201600072450A1/it
Publication of IT201600072450A1 publication Critical patent/IT201600072450A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
IT102016000072450A 2016-07-12 2016-07-12 Composizione farmaceutica a base di cellulasi per l’uso nel trattamento di malattie oculari. IT201600072450A1 (it)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT102016000072450A IT201600072450A1 (it) 2016-07-12 2016-07-12 Composizione farmaceutica a base di cellulasi per l’uso nel trattamento di malattie oculari.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102016000072450A IT201600072450A1 (it) 2016-07-12 2016-07-12 Composizione farmaceutica a base di cellulasi per l’uso nel trattamento di malattie oculari.

Publications (1)

Publication Number Publication Date
IT201600072450A1 true IT201600072450A1 (it) 2018-01-12

Family

ID=57737820

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102016000072450A IT201600072450A1 (it) 2016-07-12 2016-07-12 Composizione farmaceutica a base di cellulasi per l’uso nel trattamento di malattie oculari.

Country Status (1)

Country Link
IT (1) IT201600072450A1 (it)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710313A (en) * 1985-06-26 1987-12-01 Lion Corporation Detergent composition for contact lenses
WO2008053025A1 (en) * 2006-10-31 2008-05-08 Rheinisch-Westfaelische Technische Hochschule Aachen Therapeutic use of gba2

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710313A (en) * 1985-06-26 1987-12-01 Lion Corporation Detergent composition for contact lenses
WO2008053025A1 (en) * 2006-10-31 2008-05-08 Rheinisch-Westfaelische Technische Hochschule Aachen Therapeutic use of gba2

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ABJANI FARHAT ET AL: "Targeting cyst wall is an effective strategy in improving the efficacy of marketed contact lens disinfecting solutions againstAcanthamoeba castellaniicysts", CONTACT LENS AND ANTERIOR EYE, STOCKTON PRESS, BASINGSTOKE, GB, vol. 39, no. 3, 7 December 2015 (2015-12-07), pages 239 - 243, XP029531963, ISSN: 1367-0484, DOI: 10.1016/J.CLAE.2015.11.004 *
CEREZYME: "Prescribing Information", 5 July 2011 (2011-07-05), XP002769401, Retrieved from the Internet <URL:https://www.cerezyme.com/> [retrieved on 20170421] *
DAVID LLOYD: "Encystment in Acanthamoeba castellanii: A review", EXPERIMENTAL PARASITOLOGY, vol. 145, 12 April 2014 (2014-04-12), US, pages S20 - S27, XP055365167, ISSN: 0014-4894, DOI: 10.1016/j.exppara.2014.03.026 *
ERDOGAN MALATYALI ET AL: "In vitro amoebicidal activity of fourspecies oncysts and trophozoites", PARASITOLOGY RESEARCH ; FOUNDED AS ZEITSCHRIFT FÜR PARASITENKUNDE, SPRINGER, BERLIN, DE, vol. 110, no. 1, 28 May 2011 (2011-05-28), pages 167 - 174, XP019995117, ISSN: 1432-1955, DOI: 10.1007/S00436-011-2466-5 *
LOSELLE AND K W ANDERSON M: "The Use of Cellulase in Inhibiting Biofilm Formation from Organisms Commonly Found on Medical Implants", BIOFOULING: THE JOURNAL OF BIOADHESION AND BIOFILM RESEARCH, TAYLOR & FRANCIS, GN, vol. 19, no. 2, 1 April 2003 (2003-04-01), pages 77 - 85, XP008140825, ISSN: 0892-7014, DOI: 10.1080/0892701021000030142 *
WOOD T M ET AL: "THE MECHANISM OF FUNGAL CELLULASE ACTION SYNERGISM BETWEEN ENZYME COMPONENTS OF PENICILLIUM PINOPHILUM CELLULASE IN SOLUBILIZING HYDROGEN BOND-ORDERED CELLULOSE", BIOCHEMICAL JOURNAL, PORTLAND PRESS LTD, GB, vol. 260, no. 1, 1 January 1989 (1989-01-01), pages 37 - 43, XP008028526, ISSN: 0264-6021 *

Similar Documents

Publication Publication Date Title
CL2018000813A1 (es) Conjugados de anticuerpo-fármaco de pirrolobenzodiazepina y métodos de uso.
SV2018005610A (es) Derivados de oxopiridina sustituidos
BR112018009951A2 (pt) fármaco oftálmico
PL3500255T3 (pl) Farmaceutyczne kompozycje okulistyczne i powiązane z nimi zastosowania
CO2017002472A2 (es) Formulación de acetato de abiraterona
DK3532029T3 (da) Flydende farmaceutisk sammensætning
CL2015002897A1 (es) Inhibidores de bace1
DK3634377T3 (da) Farmaceutisk formulering
IT201600130809A1 (it) Capo di abbigliamento, in particolare per il busto
IT201600101413A1 (it) Composizione liquida per uso nel trattamento del reflusso gastroesofageo
DK3348260T3 (da) Farmaceutisk tramadol-sammensætning til oftalmisk anvendelse
DK3554534T3 (da) Farmaceutisk sammensætning omfattende insulin
BR112017013012A2 (pt) compostos de indenil, composições farmacêuticas e usos médicos destes
IT201600081379A1 (it) Composizione farmaceutica per uso nel trattamento delle patologie prostatiche.
DK3452465T3 (da) Substituerede 2,4-diaminoquinolinderivater til anvendelse til behandling af proliferative sygdomme
IT201700025666A1 (it) Composizione per l’uso nel trattamento dell’ipercolesterolemia e nella prevenzione di patologie cardiovascolari.
DK3423060T3 (da) Imatinib til anvendelse til behandling af slagtilfælde
DK3601277T3 (da) Farmaceutisk formulering
DK3432887T3 (da) Anti-tuberkulosemiddel
DK3313370T3 (da) Oftalmologisk farmaceutisk sammensætning
DK3247394T3 (da) Farmaceutisk formulering omfattende anti-egfr-antistof
IT201700111939A1 (it) Composizione farmaceutica per l’uso nel trattamento di stati infiammatori
IT201600072450A1 (it) Composizione farmaceutica a base di cellulasi per l’uso nel trattamento di malattie oculari.
ITUA20162781A1 (it) Kit di medicamenti per l’uso nel trattamento di lesioni dei tessuti tegumentari.
IT201700066486A1 (it) Siero sanguigno per uso nel trattamento di patologie neurodegenerative oftalmologiche